Literature DB >> 9796998

Expression of the membrane-type 3 matrix metalloproteinase (MT3-MMP) in human brain tissues.

Y Yoshiyama1, H Sato, M Seiki, A Shinagawa, M Takahashi, T Yamada.   

Abstract

Membrane-type 3 matrix metalloproteinase (MT3-MMP) is a novel MT-MMP which has a transmembrane domain at the C terminus, and mediates activation of pro-gelatinase A, just as does MT1-MMP. Previously, we reported that MT1-MMP was expressed on microglial cells only in the white matter [Yamada T, Yoshiyama Y, Sato H, Seiki M, Shinagawa A, Takahashi M (1995) Acta Neuropathol 90:421-424]. In the present study of both non-neurological and Alzheimer brain tissues, we examined the localization of MT3-MMP by immunohistochemistry. Anti-MT3-MMP antibodies gave positive staining of microglial cells in all brain tissues. Positively stained microglia were found not only in the white matter but also in the gray matter. Reverse transcriptase-polymerase chain reaction for MT3-MMP mRNA showed the same amount of expression in gray and white matters, while that for gelatinase A and MT1-MMP mRNA expressed much higher in the white matter than in the gray matter. These results suggest that MT3-MMP may play a role on microglial cells, although its role may be different from MT1-MMP in the brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9796998     DOI: 10.1007/s004010050904

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

Review 1.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 2.  Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.

Authors:  H L Fillmore; T E VanMeter; W C Broaddus
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  Membrane-type matrix metalloproteinase-3 regulates neuronal responsiveness to myelin through Nogo-66 receptor 1 cleavage.

Authors:  Gino B Ferraro; Charlotte J Morrison; Christopher M Overall; Stephen M Strittmatter; Alyson E Fournier
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

Review 4.  Matrix metalloproteinases and neurotrauma: evolving roles in injury and reparative processes.

Authors:  Haoqian Zhang; Hita Adwanikar; Zena Werb; Linda J Noble-Haeusslein
Journal:  Neuroscientist       Date:  2010-04       Impact factor: 7.519

5.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

6.  Biochemical and spectroscopic characterization of the catalytic domain of MMP16 (cdMMP16).

Authors:  Fan Meng; Hao Yang; Mahesh Aitha; Sam George; David L Tierney; Michael W Crowder
Journal:  J Biol Inorg Chem       Date:  2016-05-26       Impact factor: 3.358

7.  Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.

Authors:  John S K Kauwe; Matthew H Bailey; Perry G Ridge; Rachel Perry; Mark E Wadsworth; Kaitlyn L Hoyt; Lyndsay A Staley; Celeste M Karch; Oscar Harari; Carlos Cruchaga; Benjamin J Ainscough; Kelly Bales; Eve H Pickering; Sarah Bertelsen; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  PLoS Genet       Date:  2014-10-23       Impact factor: 5.917

Review 8.  Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative Disorders.

Authors:  Patrycja Brzdak; Daria Nowak; Grzegorz Wiera; Jerzy W Mozrzymas
Journal:  Front Cell Neurosci       Date:  2017-06-30       Impact factor: 5.505

9.  Perinatal Asphyxia in Rat Alters Expression of Novel Schizophrenia Risk Genes.

Authors:  Alessandra Paparelli; Keiko Iwata; Tomoyasu Wakuda; Conrad Iyegbe; Robin M Murray; Nori Takei
Journal:  Front Mol Neurosci       Date:  2017-10-27       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.